AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach

Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Keywords: Systemic sclerosis; Biomarkers; Clinical Trials
Dates:
  • Published: June 2023
  • Published (online): 30 May 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Apr 2024 12:38
Last Modified: 23 Apr 2024 13:29
Published Version: https://ard.bmj.com/content/82/Suppl_1/1616.2
Status: Published
Publisher: BMJ Publishing Group Ltd and European League Against Rheumatism
Identification Number: 10.1136/annrheumdis-2023-eular.363
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)